190 related articles for article (PubMed ID: 7538386)
1. [Terazosin in the treatment of benign prostatic hypertrophy].
Andres M; De Cobelli O; Carmignani L; Musci R; Kocjancic E; Panizzutti M; Rocco F
Arch Ital Urol Androl; 1995 Feb; 67(1):37-9. PubMed ID: 7538386
[TBL] [Abstract][Full Text] [Related]
2. [Terazosine in the treatment of benign prostatic hypertrophy].
Caine M
J Urol (Paris); 1993; 99(6):311-3. PubMed ID: 7516376
[TBL] [Abstract][Full Text] [Related]
3. Clinical experience: symptomatic management of BPH with terazosin.
Dunzendorfer U
Urology; 1988 Dec; 32(6 Suppl):27-31. PubMed ID: 2462302
[TBL] [Abstract][Full Text] [Related]
4. [Use of terazosin and alfuzosin in the treatment of benign prostatic hypertrophy (BPH): our experience].
Larosa M; Ferretti S; Salsi P; Simonazzi M
Acta Biomed Ateneo Parmense; 1994; 65(1-2):23-8. PubMed ID: 7528458
[TBL] [Abstract][Full Text] [Related]
5. Clinical comparison of selective and non-selective alpha 1A-adrenoceptor antagonists for bladder outlet obstruction associated with benign prostatic hyperplasia: studies on tamsulosin and terazosin in Chinese patients. The Chinese Tamsulosin Study Group.
Na YJ; Guo YL; Gu FL
J Med; 1998; 29(5-6):289-304. PubMed ID: 10503165
[TBL] [Abstract][Full Text] [Related]
6. A randomized, placebo-controlled multicenter study of the efficacy and safety of terazosin in the treatment of benign prostatic hyperplasia.
Lepor H; Auerbach S; Puras-Baez A; Narayan P; Soloway M; Lowe F; Moon T; Leifer G; Madsen P
J Urol; 1992 Nov; 148(5):1467-74. PubMed ID: 1279214
[TBL] [Abstract][Full Text] [Related]
7. Terazosin for benign prostatic hyperplasia.
Med Lett Drugs Ther; 1994 Feb; 36(916):15-6. PubMed ID: 7508075
[No Abstract] [Full Text] [Related]
8. Effects of terazosin in the treatment of benign prostatic hyperplasia. A pilot study.
Dunzendorfer U
Arzneimittelforschung; 1989 Oct; 39(10):1289-91. PubMed ID: 2482025
[TBL] [Abstract][Full Text] [Related]
9. Comparison of prazosin, terazosin and tamsulosin in the treatment of symptomatic benign prostatic hyperplasia: a short-term open, randomized multicenter study. BPH Medical Therapy Study Group. Benign prostatic hyperplasia.
Tsujii T
Int J Urol; 2000 Jun; 7(6):199-205. PubMed ID: 10843450
[TBL] [Abstract][Full Text] [Related]
10. [The use of terazosin hydrochloride (Hytrin) in the treatment of patients with benign prostatic hyperplasia].
Sivkov AV; Apolikhin OI; Medvedev AA
Urol Nefrol (Mosk); 1997; (5):50-3. PubMed ID: 9412019
[No Abstract] [Full Text] [Related]
11. Effect of terazosin on clinical benign prostatic hyperplasia in older adults.
Mudiyala R; Ahmed A
J Am Geriatr Soc; 2003 Mar; 51(3):424-6. PubMed ID: 12588590
[TBL] [Abstract][Full Text] [Related]
12. Terazosin in the treatment of benign prostatic hyperplasia: a multicentre, placebo-controlled trial.
Lloyd SN; Buckley JF; Chilton CP; Ibrahim I; Kaisary AV; Kirk D
Br J Urol; 1992 Nov; 70 Suppl 1():17-21. PubMed ID: 1281727
[TBL] [Abstract][Full Text] [Related]
13. A multicenter, randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of terazosin in the treatment of benign prostatic hyperplasia.
Elhilali MM; Ramsey EW; Barkin J; Casey RW; Boake RC; Beland G; Fradet Y; Trachtenberg J; Orovan WL; Schick E; Klotz LH
Urology; 1996 Mar; 47(3):335-42. PubMed ID: 8633398
[TBL] [Abstract][Full Text] [Related]
14. Terazosin. A pharmacoeconomic evaluation of its use in benign prostatic hyperplasia.
Plosker GL; Goa KL
Pharmacoeconomics; 1997 Feb; 11(2):184-97. PubMed ID: 10165827
[TBL] [Abstract][Full Text] [Related]
15. Urodynamic and clinical effects of terazosin therapy in patients with symptomatic benign prostatic hyperplasia.
Witjes WP; Rosier FW; de Wildt MJ; van Iersel MP; Debruyne FM; de La Rosette JJ
J Urol; 1996 Apr; 155(4):1317-23. PubMed ID: 8632523
[TBL] [Abstract][Full Text] [Related]
16. Terazosin in the treatment of benign prostatic hyperplasia: the United States experience.
Lepor H; Laddu A
Br J Urol; 1992 Nov; 70 Suppl 1():2-9. PubMed ID: 1281728
[TBL] [Abstract][Full Text] [Related]
17. [Therapy of benign prostatic hyperplasia: terazosin or finasteride?].
Trinkler FB
Praxis (Bern 1994); 1997 Aug; 86(34):1305-6. PubMed ID: 9381019
[No Abstract] [Full Text] [Related]
18. The safety and efficacy of terazosin for the treatment of benign prostatic hyperplasia.
Lepor H; Knapp-Maloney G; Wozniak-Petrofsky J
Int J Clin Pharmacol Ther Toxicol; 1989 Aug; 27(8):392-7. PubMed ID: 2477339
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of terazosin in patients with benign prostatic hyperplasia.
Matzkin H; Soloway MS; Rangel MC; Laddu A
Eur Urol; 1992; 21(2):126-30. PubMed ID: 1379921
[TBL] [Abstract][Full Text] [Related]
20. Side effects of terazosin in the treatment of symptomatic benign prostatic hyperplasia.
McKiernan JM; Lowe FC
South Med J; 1997 May; 90(5):509-13. PubMed ID: 9160069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
